Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SILICON LABORATORIES INC.SLAB · Entity 3682 | Sr VP WW Sales & Marketing | May 15, 2026 | May 19, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SILICON LABORATORIES INC.
Report date May 15, 2026 · Filed May 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.0001 par valueSEC Table I · non-derivative | Direct | 66,935 |
Reported balance
After 2026-05-15 transaction · row 1
1 source rowRow 1 · 2026-05-15 · Tax withholding · Disposed 4,160 · Balance 66,935 F1: Represents shares withheld to pay taxes upon the vesting of a previously reported equity award. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld to pay taxes upon the vesting of a previously reported equity award.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 20, 2021 Filed Oct 21, 2021 19:24 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | Exercise / conversionCommon Stock, $0.0001 par value | 374 | $43.82 | $16,388.68 |
DisclosureSEC source: 0001681108-21-000047 · primary_doc.xml · nonDerivative · entry 3 Tolany Brandon · CIK 0001586469 · SR VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,367 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 19, 2021 Filed Oct 21, 2021 19:24 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 1,302 | Not disclosed Strike: $43.82 | Not disclosed |
DisclosureSEC source: 0001681108-21-000047 · primary_doc.xml · derivative · entry 5 Tolany Brandon · CIK 0001586469 · SR VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,793 Underlying: Common Stock, $0.0001 par value · 1,302 shares Expires 2026-01-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Not applicable per instruction 4(c)(iii). Read SEC document |
| October 19, 2021 Filed Oct 21, 2021 19:24 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | SaleCommon Stock, $0.0001 par value | 3,302 | $150.29 | $496,257.58 |
DisclosureSEC source: 0001681108-21-000047 · primary_doc.xml · nonDerivative · entry 2 Tolany Brandon · CIK 0001586469 · SR VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,993 F1 · shares: Shares sold pursuant to Reporting Person's 10b5‐1 Trading Plan. F2 · price: Price represents the weighted average selling price. Prices range between $150.09 and $150.64 Read SEC document |
| October 19, 2021 Filed Oct 21, 2021 19:24 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | Exercise / conversionCommon Stock, $0.0001 par value | 1,302 | $43.82 | $57,053.64 |
DisclosureSEC source: 0001681108-21-000047 · primary_doc.xml · nonDerivative · entry 1 Tolany Brandon · CIK 0001586469 · SR VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,295 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 07, 2021 Filed Sep 8, 2021 20:23 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,275 | Not disclosed Strike: $43.82 | Not disclosed |
DisclosureSEC source: 0001418215-21-000002 · primary_doc.xml · derivative · entry 3 Tolany Brandon · CIK 0001586469 · Sr VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,095 Underlying: Common Stock, $0.0001 par value · 5,275 shares Expires 2026-01-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Not applicable per instruction 4(c)(iii) Read SEC document |
| September 07, 2021 Filed Sep 8, 2021 20:23 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | SaleCommon Stock, $0.0001 par value | 12,751 | $153.19 | $1,953,325.69 |
DisclosureSEC source: 0001418215-21-000002 · primary_doc.xml · nonDerivative · entry 2 Tolany Brandon · CIK 0001586469 · Sr VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,993 F1 · shares: Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan F2 · price: Price represents the weighted average selling price. Prices range between $150.20 and $155.73. Read SEC document |
| September 07, 2021 Filed Sep 8, 2021 20:23 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | Exercise / conversionCommon Stock, $0.0001 par value | 5,275 | $43.82 | $231,150.50 |
DisclosureSEC source: 0001418215-21-000002 · primary_doc.xml · nonDerivative · entry 1 Tolany Brandon · CIK 0001586469 · Sr VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,744 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2021 Filed May 18, 2021 19:34 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | GrantCommon Stock, $0.0001 par value | 5,267 | $0.00 | $0.00 |
DisclosureSEC source: 0001681108-21-000040 · primary_doc.xml · nonDerivative · entry 1 Tolany Brandon · CIK 0001586469 · SR VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,469 F1 · shares: Reflects the grant of restricted stock units (RSUs) that will entitle Reporting Person to receive one (1) share of common stock per RSU. One-third of the RSUs will vest on each of the first three anniversaries of the date of grant, and will be settled pursuant to the terms of the Issuer's 2009 Stock Incentive Plan (as amended from time to time). Read SEC document |
| April 30, 2021 Filed May 5, 2021 22:21 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | GrantCommon Stock, $0.0001 par value | 48 | $82.64 | $3,966.72 |
DisclosureSEC source: 0001681108-21-000031 · primary_doc.xml · nonDerivative · entry 1 Tolany Brandon · CIK 0001586469 · SR VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,202 F1 · shares: Shares acquired by Reporting Person through the Issuer's 2009 Employee Stock Purchase Plan on the most recent semi-annual purchase date in a transaction exempt under both Rule 166-3(c) and Rule 166-3(d). Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 23:29 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | SaleCommon Stock, $0.0001 par value | 1,921 | $152.92 | $293,759.32 |
DisclosureSEC source: 0001681108-21-000017 · primary_doc.xml · nonDerivative · entry 1 Tolany Brandon · CIK 0001586469 · SR VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,154 F1 · shares: Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan. F2 · price: Price represents the weighted average selling price. Prices range between $151.01 and $155.08 Read SEC document |
| February 12, 2021 Filed Feb 16, 2021 21:30 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | Tax withholdingCommon Stock, $0.0001 par value | 3,461 | $154.34 | $534,170.74 |
DisclosureSEC source: 0001681108-21-000013 · primary_doc.xml · nonDerivative · entry 1 Tolany Brandon · CIK 0001586469 · SR VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,075 Read SEC document |
| February 01, 2021 Filed Feb 2, 2021 17:33 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | SaleCommon Stock, $0.0001 par value | 379 | $132.30 | $50,141.70 |
DisclosureSEC source: 0001681108-21-000007 · primary_doc.xml · nonDerivative · entry 1 Tolany Brandon · CIK 0001586469 · SR VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,536 F1 · shares: Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan. Read SEC document |
| January 29, 2021 Filed Feb 1, 2021 19:48 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | Tax withholdingCommon Stock, $0.0001 par value | 459 | $131.17 | $60,207.03 |
DisclosureSEC source: 0001681108-21-000005 · primary_doc.xml · nonDerivative · entry 2 Tolany Brandon · CIK 0001586469 · SR VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,915 Read SEC document |
| January 28, 2021 Filed Feb 1, 2021 19:48 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | GrantCommon Stock, $0.0001 par value | 1,720 | $0.00 | $0.00 |
DisclosureSEC source: 0001681108-21-000005 · primary_doc.xml · nonDerivative · entry 1 Tolany Brandon · CIK 0001586469 · SR VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,374 Read SEC document |
| October 30, 2020 Filed Nov 10, 2020 16:56 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | GrantCommon Stock, $0.0001 par value | 48 | $82.64 | $3,966.72 |
DisclosureSEC source: 0001681108-20-000059 · primary_doc.xml · nonDerivative · entry 1 Tolany Brandon · CIK 0001586469 · SR VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,654 F1 · shares: These shares were acquired by Reporting Person through the Issuer's 2009 Employee Stock Purchase Plan on the most recent semi-annual purchase date, in a transaction that was exempt under both Rule 166-3(c) and Rule 166-3(d). Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 20:52 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 9,100 | Not disclosed Strike: $43.82 | Not disclosed |
DisclosureSEC source: 0001681108-20-000048 · primary_doc.xml · derivative · entry 3 Tolany Brandon · CIK 0001586469 · SR VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,370 Underlying: Common Stock, $0.0001 par value · 9,100 shares Expires 2026-01-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Not applicable per instruction 4(c)(iii). Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 20:52 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | SaleCommon Stock, $0.0001 par value | 16,170 | $105.13 | $1,699,952.10 |
DisclosureSEC source: 0001681108-20-000048 · primary_doc.xml · nonDerivative · entry 2 Tolany Brandon · CIK 0001586469 · SR VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,606 F1 · shares: Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan. F2 · price: Price represents the weighted average selling price. Prices range between $104.25 and $106.95 Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 20:52 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | Exercise / conversionCommon Stock, $0.0001 par value | 9,100 | $43.82 | $398,762.00 |
DisclosureSEC source: 0001681108-20-000048 · primary_doc.xml · nonDerivative · entry 1 Tolany Brandon · CIK 0001586469 · SR VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,776 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2020 Filed May 12, 2020 22:16 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | GrantCommon Stock, $0.0001 par value | 47 | $82.64 | $3,884.08 |
DisclosureSEC source: 0001681108-20-000036 · primary_doc.xml · nonDerivative · entry 1 Tolany Brandon · CIK 0001586469 · SR VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,676 F1 · shares: These shares were acquired by Reporting Person through the Issuer's 2009 Employee Stock Purchase Plan on the most recent semi-annual purchase date, in a transaction that was exempt under both Rule 166-3(c) and Rule 166-3(d). Read SEC document |
| February 21, 2020 Filed Feb 24, 2020 20:50 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | Tax withholdingCommon Stock, $0.0001 par value | 1,154 | $100.40 | $115,861.60 |
DisclosureSEC source: 0001681108-20-000025 · primary_doc.xml · nonDerivative · entry 1 Tolany Brandon · CIK 0001586469 · SR VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,629 Read SEC document |
| February 18, 2020 Filed Feb 19, 2020 17:25 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | SaleCommon Stock, $0.0001 par value | 2,000 | $101.99 | $203,980.00 |
DisclosureSEC source: 0001681108-20-000015 · primary_doc.xml · nonDerivative · entry 3 Tolany Brandon · CIK 0001586469 · SR VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,783 F2 · shares: Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan. F3 · price: Price represents the weighted average selling price. Prices range between $101.35 and $103.03 Read SEC document |
| February 15, 2020 Filed Feb 19, 2020 17:25 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | GrantCommon Stock, $0.0001 par value | 6,687 | $0.00 | $0.00 |
DisclosureSEC source: 0001681108-20-000015 · primary_doc.xml · nonDerivative · entry 2 Tolany Brandon · CIK 0001586469 · SR VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,783 F1 · shares: Reflects the grant of restricted stock units (RSUs) that will entitle Reporting Person to receive one (1) share of common stock per RSU. One-third of the RSUs will vest on each of the first three anniversaries of the date of grant, and will be settled pursuant to the terms of the Issuer's 2009 Stock Incentive Plan as amended and restated on April 20, 2017. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 17:25 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | Tax withholdingCommon Stock, $0.0001 par value | 8,526 | $104.20 | $888,409.20 |
DisclosureSEC source: 0001681108-20-000015 · primary_doc.xml · nonDerivative · entry 1 Tolany Brandon · CIK 0001586469 · SR VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,096 Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 15:50 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | Tax withholdingCommon Stock, $0.0001 par value | 581 | $98.31 | $57,118.11 |
DisclosureSEC source: 0001681108-20-000012 · primary_doc.xml · nonDerivative · entry 1 Tolany Brandon · CIK 0001586469 · SR VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,622 Read SEC document |
| January 23, 2020 Filed Jan 28, 2020 18:36 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | GrantCommon Stock, $0.0001 par value | 2,389 | $0.00 | $0.00 |
DisclosureSEC source: 0001681108-20-000006 · primary_doc.xml · nonDerivative · entry 1 Tolany Brandon · CIK 0001586469 · SR VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,203 Read SEC document |
| October 31, 2019 Filed Nov 5, 2019 19:09 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | GrantCommon Stock, $0.0001 par value | 56 | $69.30 | $3,880.80 |
DisclosureSEC source: 0001681108-19-000045 · primary_doc.xml · nonDerivative · entry 1 Tolany Brandon · CIK 0001586469 · SR VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,814 F1 · shares: These shares were acquired by Reporting Person through the Issuer's 2009 Employee Stock Purchase Plan on the most recent semi-annual purchase date, in a transaction that was exempt under both Rule 166-3(c) and Rule 166-3(d). Read SEC document |
| September 26, 2019 Filed Sep 27, 2019 16:01 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | SaleCommon Stock, $0.0001 par value | 1,000 | $113.94 | $113,940.00 |
DisclosureSEC source: 0001681108-19-000039 · primary_doc.xml · nonDerivative · entry 1 Tolany Brandon · CIK 0001586469 · Sr VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,758 F1 · shares: Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan. Read SEC document |
| April 30, 2019 Filed May 3, 2019 19:59 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | GrantCommon Stock, $0.0001 par value | 56 | $69.30 | $3,880.80 |
DisclosureSEC source: 0001681108-19-000035 · primary_doc.xml · nonDerivative · entry 1 Tolany Brandon · CIK 0001586469 · Sr VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,758 F1 · shares: These shares were acquired by Reporting Person through the Issuer's 2009 Employee Stock Purchase Plan on the most recent semi-annual purchase date, in a transaction that was exempt under both Rule 166-3(c) and Rule 166-3(d). Read SEC document |
| February 22, 2019 Filed Feb 25, 2019 20:21 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | GrantCommon Stock, $0.0001 par value | 8,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001681108-19-000020 · primary_doc.xml · nonDerivative · entry 1 Tolany Brandon · CIK 0001586469 · Sr VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,702 F1 · shares: Reflects the grant of restricted stock units (RSUs) that will entitle Reporting Person to receive one (1) share of common stock per RSU. One-third of the RSUs will vest on each of February 22, 2020, February 15, 2021, and February 15, 2022 and will be settled pursuant to the terms of the Issuer's 2009 Stock Incentive Plan as amended and restated on April 20, 2017. Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 21:35 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | Tax withholdingCommon Stock, $0.0001 par value | 5,466 | $88.34 | $482,866.44 |
DisclosureSEC source: 0001681108-19-000014 · primary_doc.xml · nonDerivative · entry 1 Tolany Brandon · CIK 0001586469 · Sr VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,895 Read SEC document |
| January 24, 2019 Filed Jan 28, 2019 21:06 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | GrantCommon Stock, $0.0001 par value | 2,059 | $0.00 | $0.00 |
DisclosureSEC source: 0001681108-19-000006 · primary_doc.xml · nonDerivative · entry 1 Tolany Brandon · CIK 0001586469 · Sr VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,361 Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 19:54 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | GrantCommon Stock, $0.0001 par value | 56 | $69.30 | $3,880.80 |
DisclosureSEC source: 0001418215-18-000004 · primary_doc.xml · nonDerivative · entry 1 Tolany Brandon · CIK 0001586469 · Sr VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,302 F1 · shares: These shares were acquired by Reporting Person through the Issuer's 2009 Employee Stock Purchase Plan on the most recent semi-annual purchase date, in a transaction that was exempt under both Rule 166-3(d) and Rule 166-3(c). Read SEC document |
| May 02, 2018 Filed May 3, 2018 20:18 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | SaleCommon Stock, $0.0001 par value | 200 | $94.80 | $18,960.00 |
DisclosureSEC source: 0001681108-18-000031 · primary_doc.xml · nonDerivative · entry 2 Tolany Brandon · CIK 0001586469 · SR VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,246 F2 · shares: Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan. Read SEC document |
| April 30, 2018 Filed May 3, 2018 20:18 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | GrantCommon Stock, $0.0001 par value | 200 | $39.78 | $7,956.00 |
DisclosureSEC source: 0001681108-18-000031 · primary_doc.xml · nonDerivative · entry 1 Tolany Brandon · CIK 0001586469 · SR VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,446 F1 · shares: These shares were acquired by Reporting Person through the Issuer's 2009 Employee Stock Purchase Plan on the most recent semi-annual purchase date, in a transaction that was exempt under both Rule 166-3(d) and Rule 166-3(c). Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 17:37 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | SaleCommon Stock, $0.0001 par value | 9,060 | $91.47 | $828,718.20 |
DisclosureSEC source: 0001681108-18-000020 · primary_doc.xml · nonDerivative · entry 1 Tolany Brandon · CIK 0001586469 · SR VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,246 F1 · shares: Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan. F2 · price: Price represents the weighted average selling price. Prices range between $90.85 and $92.30 Read SEC document |
| February 15, 2018 Filed Feb 16, 2018 20:49 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | Tax withholdingCommon Stock, $0.0001 par value | 5,876 | $93.20 | $547,643.20 |
DisclosureSEC source: 0001681108-18-000016 · primary_doc.xml · nonDerivative · entry 2 Tolany Brandon · CIK 0001586469 · SR VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,306 Read SEC document |
| February 15, 2018 Filed Feb 16, 2018 20:49 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | GrantCommon Stock, $0.0001 par value | 7,916 | $0.00 | $0.00 |
DisclosureSEC source: 0001681108-18-000016 · primary_doc.xml · nonDerivative · entry 1 Tolany Brandon · CIK 0001586469 · SR VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,182 F1 · shares: Reflects the grant of restricted stock units (RSUs) that will entitle Reporting Person to receive one (1) share of common stock per RSU. One-third of the RSUs will vest on each of the first three anniversaries of the date of grant, and will be settled pursuant to the terms of the Issuer's 2009 Stock Incentive Plan as amended and restated on April 20, 2017. Read SEC document |
| January 29, 2018 Filed Jan 30, 2018 20:25 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 18,235 | Not disclosed Strike: $43.82 | Not disclosed |
DisclosureSEC source: 0001681108-18-000006 · primary_doc.xml · derivative · entry 3 Tolany Brandon · CIK 0001586469 · SR VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,470 Underlying: Common Stock, $0.0001 par value · 18,235 shares Expires 2026-01-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Not applicable per instruction 4(c)(iii). Read SEC document |
| January 29, 2018 Filed Jan 30, 2018 20:25 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | SaleCommon Stock, $0.0001 par value | 18,235 | $95.00 | $1,732,325.00 |
DisclosureSEC source: 0001681108-18-000006 · primary_doc.xml · nonDerivative · entry 2 Tolany Brandon · CIK 0001586469 · SR VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,266 F1 · shares: Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan. Read SEC document |
| January 29, 2018 Filed Jan 30, 2018 20:25 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | Exercise / conversionCommon Stock, $0.0001 par value | 18,235 | $43.82 | $799,057.70 |
DisclosureSEC source: 0001681108-18-000006 · primary_doc.xml · nonDerivative · entry 1 Tolany Brandon · CIK 0001586469 · SR VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,501 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 25, 2018 Filed Jan 29, 2018 23:11 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | GrantCommon Stock, $0.0001 par value | 6,348 | $0.00 | $0.00 |
DisclosureSEC source: 0001681108-18-000005 · primary_doc.xml · nonDerivative · entry 1 Tolany Brandon · CIK 0001586469 · SR VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,266 Read SEC document |
| November 02, 2017 Filed Nov 6, 2017 20:17 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | SaleCommon Stock, $0.0001 par value | 200 | $93.25 | $18,650.00 |
DisclosureSEC source: 0001681108-17-000045 · primary_doc.xml · nonDerivative · entry 2 Tolany Brandon · CIK 0001586469 · Sr VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,918 F2 · shares: Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan. Read SEC document |
| October 31, 2017 Filed Nov 6, 2017 20:17 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | GrantCommon Stock, $0.0001 par value | 200 | $39.78 | $7,956.00 |
DisclosureSEC source: 0001681108-17-000045 · primary_doc.xml · nonDerivative · entry 1 Tolany Brandon · CIK 0001586469 · Sr VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,118 F1 · shares: These shares were acquired by Reporting Person through the Issuer's 2009 Employee Stock Purchase Plan on the most recent semi-annual purchase date, in a transaction that was exempt under both Rule 166-3(d) and Rule 166-3(c). Read SEC document |
| May 02, 2017 Filed May 3, 2017 21:44 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 9,117 | Not disclosed Strike: $43.82 | Not disclosed |
DisclosureSEC source: 0001681108-17-000026 · primary_doc.xml · derivative · entry 7 Tolany Brandon · CIK 0001586469 · SR VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,705 Underlying: Common Stock, $0.0001 par value · 9,117 shares Expires 2026-01-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Not applicable per instruction 4(c)(iii). Read SEC document |
| May 02, 2017 Filed May 3, 2017 21:44 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | SaleCommon Stock, $0.0001 par value | 8,591 | $70.84 | $608,586.44 |
DisclosureSEC source: 0001681108-17-000026 · primary_doc.xml · nonDerivative · entry 5 Tolany Brandon · CIK 0001586469 · SR VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,918 Read SEC document |
| May 02, 2017 Filed May 3, 2017 21:44 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | SaleCommon Stock, $0.0001 par value | 9,117 | $70.98 | $647,124.66 |
DisclosureSEC source: 0001681108-17-000026 · primary_doc.xml · nonDerivative · entry 4 Tolany Brandon · CIK 0001586469 · SR VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,509 F3 · price: Price represents the weighted average selling price. Prices range between $70.60 and $71.30 Read SEC document |
| May 02, 2017 Filed May 3, 2017 21:44 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | Exercise / conversionCommon Stock, $0.0001 par value | 9,117 | $43.82 | $399,506.94 |
DisclosureSEC source: 0001681108-17-000026 · primary_doc.xml · nonDerivative · entry 3 Tolany Brandon · CIK 0001586469 · SR VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,626 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2017 Filed May 3, 2017 21:44 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 9,118 | Not disclosed Strike: $43.82 | Not disclosed |
DisclosureSEC source: 0001681108-17-000026 · primary_doc.xml · derivative · entry 6 Tolany Brandon · CIK 0001586469 · SR VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,822 Underlying: Common Stock, $0.0001 par value · 9,118 shares Expires 2026-01-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Not applicable per instruction 4(c)(iii). Read SEC document |
| May 01, 2017 Filed May 3, 2017 21:44 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | SaleCommon Stock, $0.0001 par value | 9,118 | $72.07 | $657,134.26 |
DisclosureSEC source: 0001681108-17-000026 · primary_doc.xml · nonDerivative · entry 2 Tolany Brandon · CIK 0001586469 · SR VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,509 F2 · price: Price represents the weighted average selling price. Prices range between $72.00 and $72.30 Read SEC document |
| May 01, 2017 Filed May 3, 2017 21:44 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | Exercise / conversionCommon Stock, $0.0001 par value | 9,118 | $43.82 | $399,550.76 |
DisclosureSEC source: 0001681108-17-000026 · primary_doc.xml · nonDerivative · entry 1 Tolany Brandon · CIK 0001586469 · SR VP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,627 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 200 shares purchased by Reporting Person through the Issuer's 2009 Employee Stock Purchase Plan on the most recent semi-annual purchase date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.